financetom
Business
financetom
/
Business
/
Flex Insider Sold Shares Worth $2,653,065, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Flex Insider Sold Shares Worth $2,653,065, According to a Recent SEC Filing
May 31, 2024 12:48 AM

03:26 AM EDT, 05/31/2024 (MT Newswires) -- Michael D Capellas, Director, on May 28, 2024, sold 78,872 shares in Flex (FLEX) for $2,653,065. Following the Form 4 filing with the SEC, Capellas has control over a total of 219,037 shares of the company, with 219,037 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/866374/000162828024025916/xslF345X03/wk-form4_1717114944.xml

Price: 33.60, Change: -0.18, Percent Change: -0.53

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hungary's government seeks more corporate contributions, media funding limits
Hungary's government seeks more corporate contributions, media funding limits
Jul 8, 2024
* Hungary places measures in context of Ukraine war * Government has previously sought budget contributions * Plans to send back foreign funds given to Hungarian media * Orban met Xi on Monday, Putin on Friday (Updates throughout with media funding legislation; adds paragraphs 1-2, 6-9) By Boldizsar Gyori and Anita Komuves BUDAPEST, July 8 (Reuters) - Hungary's government laid...
Eli Lilly Strikes $3.2 Billion Deal to Acquire Morphic
Eli Lilly Strikes $3.2 Billion Deal to Acquire Morphic
Jul 8, 2024
09:06 AM EDT, 07/08/2024 (MT Newswires) -- Eli Lilly ( LLY ) will buy biopharmaceutical company Morphic ( MORF ) for roughly $3.2 billion in a bid to expand its immunology portfolio with oral therapies targeting cell proteins for chronic diseases. The drugmaker will launch a tender offer to acquire all outstanding shares of Morphic ( MORF ) for $57...
Precision Drilling Extends Senior Credit Facility, Provides Update on 2024 Debt Repayment, Share Buyback
Precision Drilling Extends Senior Credit Facility, Provides Update on 2024 Debt Repayment, Share Buyback
Jul 8, 2024
09:06 AM EDT, 07/08/2024 (MT Newswires) -- Precision Drilling Corporation ( PDS ) has extended its senior credit facility and says it is on track to meet its 2024 debt reduction and share repurchase targets. The company extended its credit facility's maturity date to June 28, 2027, and revised the size to US$375 million (from US$447 million). The facility includes...
Merus Begins Phase 2 Trial of Colorectal Cancer Drug Candidate
Merus Begins Phase 2 Trial of Colorectal Cancer Drug Candidate
Jul 8, 2024
09:06 AM EDT, 07/08/2024 (MT Newswires) -- Merus (MRUS) said Monday it has dosed first patient in its phase 2 trial of petosemtamab combined with standard chemotherapy to treat second-line metastatic colorectal cancer. The open-label trial aims to evaluate the safety and preliminary antitumor activity of petosemtamab and chemotherapy in approximately 40 patients without prior EGFR inhibitor treatment. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved